Breast Cancer

Latest News


Latest Videos


More News

“Novel approaches to immunotherapy, targeted therapy and combinations with standard chemotherapy are all areas of current research interest,” says an expert at Dana-Farber Cancer Institute Sarcoma Center in Boston. “(Secondary breast cancer) can be very challenging when it recurs, so we need to continue to work toward improving systemic therapies through ongoing international trials and collaboration across the community of patients and physicians. That’s what’s going to help us improve outcomes.”